RPTX Message Board Post 10054508 | Repare Therapeutics Inc.
home / stock / rptx / rptx message board
ebrenn02
(investorshub)
Posted on: Jun/03/2022 13:44:23
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169044384
$RPTX: Well, good morning, FOLKS!!! (Just trying to
News, Short Squeeze, Breakout and More Instantly...
-
Overall response of 18.2% in heavily pretreated patients across gastrointestinal tumors with target alterations regardless of prior irinotecan exposure Prolonged clinical benefit in patients with CRC, with 40% of irinotecan-naïve patients receiving treatment for greater than nine mon...
-
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the first patient has been dosed in the Company’s camonsertib monotherapy non-small cell lung cancer (NSCLC) expansion of th...
-
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to lunresertib in combination with camonsertib for t...